Tag Archives: The Stem Cell Blog

CA Stem Cell Agency Chief Randy Mills to Leave After Three Years … – Xconomy

Continue reading

2017-05-02 NEWS

Sacramento Bee

CA Stem Cell Agency Chief Randy Mills to Leave After Three Years …
Xconomy
The head of California’s stem-cell agency is stepping down after three years on the job. C. Randall Mills, known as Randy, is leaving the agency to run a n.
CIRM — California’s stem cell research funding agency — to lose …San Francisco Business Times
California stem cell agency president steps down as worries mount …Sacramento Bee

all 3 news articles »

Continue reading

2017-05-02 NEWS

Researchers Publish Two New Methods for Analysis of CRISPR Off-Target Effects
GenomeWeb
NEW YORK (GenomeWeb) – Two studies published simultaneously in Nature Methods yesterday describe new methods for analyzing the off-target effects of CRISPR/Cas-9 genome editing. One method identifies off-target mutations associated with …

Continue reading

2017-05-02 NEWS

Researchers Publish Two New Methods for Analysis of CRISPR Off-Target Effects
GenomeWeb
NEW YORK (GenomeWeb) – Two studies published simultaneously in Nature Methods yesterday describe new methods for analyzing the off-target effects of CRISPR/Cas-9 genome editing. One method identifies off-target mutations associated with …

Continue reading

2017-05-02 NEWS

California stem cell agency boss finds new job
San Francisco Business Times
Randy Mills, who came in to right California’s semi-public stem cell research funding agency, is leaving to head the National Marrow Donor Program. Mills three years ago came in as CEO of the California Institute for Regenerative Medicine with an eye

Continue reading

2017-05-02 NEWS

The Oracle Dispatch

Unproven stem cell therapies – promise versus evidence
BioNews
The ability of stem cells to divide into different mature cell types has ignited the field of regenerative medicine. Stem cells promise to repair and regenerate damaged or diseased tissues without the need for orthodox medical or surgical interventions
US Stem Cell Inc (OTCMKTS:USRM) Explodes Higher Ahead of RMAT DecisionThe Oracle Dispatch
US Stem Cell Inc (OTCMKTS:USRM) Extends Rise After Private Equity Firm Commits to Share PurchaseStreet Register
US Stem Cell Inc (OTCMKTS:USRM) Receives Institutional Fund InjectionStockNewsUnion
Lenox Ledger
all 5 news articles »